Cerity Partners
TMDX icon

Cerity Partners’s Transmedics TMDX Stock Holding History

Cerity Partners’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.4K Buy
+1,000
New +$84.6K ﹤0.01% 3271

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Cerity Partners's TMDX Position: Q2 2026 in Review

Cerity Partners opened a new position in Transmedics (TMDX) in Q2 2026: 2,917 shares worth $194K. The stake represents ﹤0.01% of the portfolio and ranks #3060 among its holdings. This is a return to the name: Cerity Partners previously reported a position in TMDX as recently as Q3 2025.

Cerity Partners first reported a position in TMDX in Q2 2025 and has held it in 3 quarters since. The position peaked at $275K in Q2 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Cerity Partners held 2,917 shares of Transmedics worth $194K as of Q2 2026.
  • Transmedics was a new Cerity Partners position in Q2 2026.
  • Transmedics made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #3060 holding.
  • Cerity Partners first reported a position in Transmedics in Q2 2025 and has held it in 3 quarters since.
  • Cerity Partners's Transmedics position peaked at $275K in Q2 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.